GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CardioComm Solutions Inc (TSXV:EKG) » Definitions » EV-to-EBIT

CardioComm Solutions (TSXV:EKG) EV-to-EBIT : -27.68 (As of May. 31, 2024)


View and export this data going back to 1989. Start your Free Trial

What is CardioComm Solutions EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, CardioComm Solutions's Enterprise Value is C$1.91 Mil. CardioComm Solutions's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.07 Mil. Therefore, CardioComm Solutions's EV-to-EBIT for today is -27.68.

The historical rank and industry rank for CardioComm Solutions's EV-to-EBIT or its related term are showing as below:

TSXV:EKG' s EV-to-EBIT Range Over the Past 10 Years
Min: -10771.6   Med: -7.25   Max: 2739.81
Current: -27.68

During the past 13 years, the highest EV-to-EBIT of CardioComm Solutions was 2739.81. The lowest was -10771.60. And the median was -7.25.

TSXV:EKG's EV-to-EBIT is ranked worse than
100% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 17.91 vs TSXV:EKG: -27.68

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. CardioComm Solutions's Enterprise Value for the quarter that ended in Dec. 2023 was C$1.91 Mil. CardioComm Solutions's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.07 Mil. CardioComm Solutions's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -3.61%.


CardioComm Solutions EV-to-EBIT Historical Data

The historical data trend for CardioComm Solutions's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioComm Solutions EV-to-EBIT Chart

CardioComm Solutions Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.05 -1,991.49 161.34 184.63 -27.68

CardioComm Solutions Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 184.63 -84.27 -18.46 -57.69 -27.68

Competitive Comparison of CardioComm Solutions's EV-to-EBIT

For the Health Information Services subindustry, CardioComm Solutions's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CardioComm Solutions's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CardioComm Solutions's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where CardioComm Solutions's EV-to-EBIT falls into.



CardioComm Solutions EV-to-EBIT Calculation

CardioComm Solutions's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1.910/-0.069
=-27.68

CardioComm Solutions's current Enterprise Value is C$1.91 Mil.
CardioComm Solutions's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CardioComm Solutions  (TSXV:EKG) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

CardioComm Solutions's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-0.069/1.90965
=-3.61 %

CardioComm Solutions's Enterprise Value for the quarter that ended in Dec. 2023 was C$1.91 Mil.
CardioComm Solutions's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CardioComm Solutions EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of CardioComm Solutions's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


CardioComm Solutions (TSXV:EKG) Business Description

Traded in Other Exchanges
Address
18 Wynford Drive, Suite 305, North York, ON, CAN, M3C 3S2
CardioComm Solutions Inc develops advanced software, hardware and core laboratory reading services related to the electrocardiogram ("ECG") and ambulatory arrhythmia monitoring systems for medical and consumer markets. It engages in the provision of management software solutions. It specializes in software engineering of computer-based electrocardiogram management and reporting software. The company's products include software, Gems Win, Global ECG Management System, GlobalCardio 12 lead; hardware, include handheld ECG monitor; Asp Services, include ECG management service and smart monitoring; software modules, consists of Win Air, Auto attendant, HL7 interface and EMR integration; and other products, include ECG viewer SDK and QRS 12 lead universal.
Executives
Steven Vincent Benyo Director

CardioComm Solutions (TSXV:EKG) Headlines